Therapeutics in the Treatment of COVID-19 for Children and Adolescents
Pediatric Infection and Vaccine
; 29(1):1-15, 2022.
Article
in Korean
| EMBASE | ID: covidwho-1887349
ABSTRACT
Coronavirus disease 2019 (COVID-19) presents as a mild-to-moderate respiratory illness in most children. However, a small proportion of children with COVID-19 develop severe or critical illnesses. Although pediatric clinical trials for the treatment of COVID-19 are sparse, some drugs are available for children and adolescents with severe COVID-19. This review summarizes clinical data focusing on antiviral agents and immunomodulators for use in treating COVID-19. In addition, current recommendations for therapeutics for children and adolescents with COVID-19 are discussed.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
Korean
Journal:
Pediatric Infection and Vaccine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS